SKYEPHARMA TO PRESENT AT SACHS ASSOCIATES 7TH ANNUAL BIOTECH INVESTOR IN EUROPE CONFERENCE LONDON, UK, 25 September 2007-- SkyePharma PLC (LSE: SKP) announces today that the Company's Chief Operating Officer, Dr Ken Cunningham, will make a presentation at the Sachs Associates 7th Annual Biotech Investor in Europe Conference in Zurich. Dr Cunningham will deliver his presentation on Tuesday 2 October 2007 at 3.35 p.m. CEST (2.35 p.m. UK). Investors may access the slide presentation at www.skyepharma.com under the Investor Relations tab. For further information please contact: SkyePharma PLC Frank Condella +44 20 7491 1777 Ken Cunningham Peter Grant Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113 Deborah Scott Trout Group (US Enquiries) Christine Labaree +1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Company has eleven approved products in the areas of oral, inhalation and topical delivery that are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com This information is provided by RNS The company news service from the London Stock Exchange END
SkyePharma PLC announces Sachs Biotech Conference
| Source: SkyePharma PLC
London, UK--(Marketwire - September 25, 2007) -